Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis. (Q38249953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

1 reference

title

Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Giuseppe Rengo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Fabio Monzani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Nicola Ferrara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Giuseppe Pasqualetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Grazia Daniela Femminella

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Michele Tagliati

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

15 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurology, Neurosurgery and Psychiatry

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

767-773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25224676%20AND%20SRC:MED&resulttype=core&format=json

Ageing, neurodegeneration and Parkinson's disease

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Non-motor symptoms of Parkinson's disease: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Prevalence of gait disorders in hospitalized neurological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Cognition and the risk of hospitalization for serious falls in the elderly: results from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Pharmacological treatment of Parkinson disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Meta-analysis: principles and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Explaining heterogeneity in meta-analysis: a comparison of methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764

Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308764